Management

Paul van der Schueren, President, Chief Executive Officer (CEO)

Paul founded Oligovax, negotiated the partnership contract with Assistance Publique - Hôpitaux de Paris and participated in arranging several financing rounds. Paul brings his experience in growing and running start-ups and is in charge of financial and legal matters. He is a graduate of Solvay MBA.

Pr Antoine Carpentier, Scientific Advisor

Inventor of stabilized oligonucleotides with anti-tumor action, Antoine (MD, PhD) is Professor in Paris Hospital (AP-HP), Head of Department of Neuro-Oncology (Saint-Louis Hospital) and Oligovax's scientific interlocutor).